Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are an increasingly prevalent class of drugs for managing overweight/obesity and type 2 diabetes mellitus. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.